Key advances in the clinical approach to ANCA-associated vasculitis.
about
Mechanisms of Autoantibody-Induced Pathology.Thrombosis in vasculitis: from pathogenesis to treatment.Linking classification and therapeutic management of vasculitides.Peripheral blood natural killer cell percentages in granulomatosis with polyangiitis correlate with disease inactivity and stage.Applying complement therapeutics to rare diseases.High-mobility group box 1 potentiates antineutrophil cytoplasmic antibody-inducing neutrophil extracellular traps formation.Accelerated atherosclerosis in patients with chronic inflammatory rheumatologic conditionsNew insights on biomarkers in systemic vasculitis.Drug-Induced Vasculitis: New Insights and a Changing Lineup of Suspects.Current clinical evidence of tocilizumab for the treatment of ANCA-associated vasculitis: a prospective case series for microscopic polyangiitis in a combination with corticosteroids and literature review.18F-fluoro-deoxy-glucose positron emission tomography combined with computed tomography can reliably rule-out infection and cancer in patients with anti-neutrophil cytoplasmic antibody-associated vasculitis suspected of disease relapsePredictors of Poor Outcome in ANCA-Associated Vasculitis (AAV).Thoracic intradural extramedullary lesions causing progressive myelopathy as an initial manifestation of granulomatosis with polyangiitis: a case report and review of literature.Interleukin-9 and T helper type 9 cells in rheumatic diseases.Hypertrophic pachymeningitis is a characteristic manifestation of granulomatosis with polyangiitis: A retrospective study of anti-neutrophil cytoplasmic antibody-associated vasculitis.An emerging role for neutrophil extracellular traps in noninfectious disease.Clinicopathologic characteristics of Weneger's granulomatosis: A report of three cases.Plasma levels of M-CSF are increased in ANCA-associated vasculitides with active nephritis.Tuberculosis mimicking primary systemic vasculitis: not to be missed!CT Features of Vasculitides Based on the 2012 International Chapel Hill Consensus Conference Revised Classification.Biomarkers in connective tissue diseases.Th17 and Treg lymphocytes as cellular biomarkers of disease activity in Granulomatosis with Polyangiitis.Granulomatosis with Polyangiitis Complicated by Hypertrophic Pachymeningitis Presenting with Simultaneous Multiple Intracerebral Hemorrhages.[Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides. German version].Effector memory T‑cells in the pathogenesis of ANCA-associated vasculitides.Corticosteroid-free treatment of tocilizumab monotherapy for microscopic polyangiitis: a single-arm, single-center, clinical trial.Rare case of eosinophilic granulomatosis with polyangiitis in two patients with α-1-antitrypsin deficiency (PiSZ).Cutaneous Drug Reactions in the Elderly.Pathogenetic and Clinical Aspects of Anti-Neutrophil Cytoplasmic Autoantibody-Associated Vasculitides.Granulomatosis with Polyangiitis Localized in the Greater Omentum.Effect of plasma exchange on in-hospital mortality in patients with pulmonary hemorrhage secondary to antineutrophil cytoplasmic antibody-associated vasculitis: A propensity-matched analysis using a nationwide administrative database.Clinical and pathologic characteristics of pauci-immune anti-myeloperoxidase antibody associated glomerulonephritis with nephrotic range proteinuria
P2860
Q33740580-B14FEF6F-7EA1-4D72-A709-B45AFA954DF5Q35440601-3DF132DB-753F-4B9C-9E4C-C036086CD188Q35672892-CC5513E4-57E1-4C27-AAF8-3F1FFEDC069DQ36304029-5E55E676-BFF8-4AF9-A603-0769E9BD2A62Q36315497-E869FF6D-3904-487C-8F19-F06AAF4F5699Q36477462-A5BA917D-F659-41BB-995E-FEBD05A273D2Q36746012-FD6B1BF9-8C57-4291-A55B-DDDFAB1FB717Q38367777-70F8B778-0418-4DB4-B27A-4C44B5CF4702Q38616743-E654F063-B2D8-4D2A-BFF3-8056B1BFA05BQ38653449-DC96F59A-625F-4289-A299-48837D5E5378Q38660279-0A136C1D-E278-4FE2-8A50-31E379B72798Q38798628-E3A4E76D-EF1C-48EF-8B50-BB7C14441543Q38814792-D7964926-8C93-466B-A56C-9E98E76C194FQ38829766-1D50CBAB-47CC-4886-BCB8-A172AAB9BA93Q38952160-DB7BF134-BB53-4626-AEE8-602D7BB0B561Q39166302-C0295551-0EC6-4578-8FF3-E864C8965ADFQ39655488-CF3E7057-54D6-4D26-8687-42094843D570Q40182072-71C8A649-C2E1-4A34-806B-3AFB90FF0B09Q40370300-2ABF546F-8866-4CA9-83D7-1E727CC921E0Q41350560-5C29CFC0-7323-4D72-80B8-2F3575F59DA8Q47314399-56DAEC43-4681-4899-9480-5A9CE44966E4Q47925876-81EC1DEA-5DDF-4CE0-B978-55DEEDFBEEEEQ49567397-54A7BE37-BB67-448D-9848-B56BA2B38B87Q50667073-A7EE1841-9BFE-4209-B647-D901350715BDQ50667082-9A0FABB9-C4BC-4EB0-A871-136BCA96A425Q50700806-D73046B9-D1A9-469A-93F2-8642C9C3EC79Q51529985-F268B9E1-469F-49A3-AEEF-D8F5ED3965C0Q51803601-52366AE3-7624-4816-B801-18F3A7E7F505Q52311683-5CE2D64C-9B29-4ADF-9B7F-839C0B423039Q54969580-522800F1-4CBB-4D7A-B2A4-6E2E8C183628Q55002763-17E782A2-F766-454B-BD5C-05FD110A33D2Q57025010-4DE6DE05-B05D-464F-BF85-79569C33BCA2
P2860
Key advances in the clinical approach to ANCA-associated vasculitis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Key advances in the clinical approach to ANCA-associated vasculitis.
@en
type
label
Key advances in the clinical approach to ANCA-associated vasculitis.
@en
prefLabel
Key advances in the clinical approach to ANCA-associated vasculitis.
@en
P2860
P356
P1476
Key advances in the clinical approach to ANCA-associated vasculitis.
@en
P2860
P2888
P304
P356
10.1038/NRRHEUM.2014.104
P407
P577
2014-07-01T00:00:00Z
P5875
P6179
1005155582